solving the biggest bottlenecks in women’s health innovation
Funding
Data
Operational support
Top pharma companies derive more than 60 percent of their revenue from therapies for diseases that affect women uniquely, differently, or disproportionately
— McKinsey & Company, 2025Femtech is forecasted to reach $60bn+ TAM by 2027
-Allied Market Research, 2023closing the women’s health gap could unlock $400 billion in global GDP annually by 2040
-World Economic Forum, 2025recent news
